Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225036 · ClinicalTrials.gov registry record · NA
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
A NA study of Non-Small Cell Lung Cancer and Melanoma, sponsored by Jordan Kharofa.
- Recruiting
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT07225036 is a NA study of Non-Small Cell Lung Cancer and Melanoma that is actively recruiting participants, run by Jordan Kharofa. The registered enrollment target is 21 participants, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07225036, a NA study of Non-Small Cell Lung Cancer and Melanoma, is actively recruiting participants, sponsored by Jordan Kharofa.
- RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if adding Low-Dose Liver Radiation (LD-LRT) improves progression free survival (PFS). This study is for patients with either melanoma or non-small cell lung cancer (NSCLC), with liver metastases, and receiving immunotherapy.
Conditions Studied
Interventions
- RADIATION LD-LRT
Study Locations (1)
Ohio
- University of Cincinnati Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2029-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07225036
The ClinicalTrials.gov registry entry for NCT07225036 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Jordan Kharofa, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which LD-LRT is the first listed.
NCT07225036 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07225036 about?
NCT07225036 is a clinical study titled "Promoting Immunotherapy Efficacy With Low-Dose Liver RT". The purpose of this study is to see if adding Low-Dose Liver Radiation (LD-LRT) improves progression free survival (PFS). This study is for patients with either melanoma or non-small cell lung cancer (NSCLC), with liver metastases, and receiving immunotherapy.
What is the current status of trial NCT07225036?
This trial is currently recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2025-12-15. Estimated completion is 2029-12-15.
What conditions does trial NCT07225036 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer, Melanoma, Liver Metastases, Low-Dose Liver Radiation (LD-LRT).
What interventions are being tested in trial NCT07225036?
The interventions under investigation include: LD-LRT (RADIATION).
Who is sponsoring clinical trial NCT07225036?
This trial is sponsored by Jordan Kharofa, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225036 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
RECRUITING · NA
-
High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
RECRUITING · NA
-
Feasibility Testing of a Dyadic Exercise Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.